In vivo treatment with interferon causes augmentation of IL-2 induced lymphokine-activated killer cells in the organs of mice (Q67696139)

From Wikidata

Jump to navigation Jump to search

scientific article published on 01 August 1991

edit

Language	Label	Description	Also known as
English	In vivo treatment with interferon causes augmentation of IL-2 induced lymphokine-activated killer cells in the organs of mice	scientific article published on 01 August 1991

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1713814

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1713814%20AND%20SRC:MED&resulttype=core&format=json

retrieved

17 September 2019

title

In vivo treatment with interferon causes augmentation of IL-2 induced lymphokine-activated killer cells in the organs of mice (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1713814

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1713814%20AND%20SRC:MED&resulttype=core&format=json

retrieved

17 September 2019

main subject

immunology

1 reference

stated in

Crossref

DOI

10.1111/J.1365-2249.1991.TB05726.X

reference URL

https://api.crossref.org/works/10.1111/J.1365-2249.1991.TB05726.X

retrieved

6 November 2022

author name string

R. K. Puri

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1713814

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1713814

retrieved

6 November 2022

P. Leland

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1713814

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1713814

retrieved

6 November 2022

language of work or name

English

1 reference

stated in

National Center for Biotechnology Information

PubMed publication ID

1713814

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1713814

retrieved

6 November 2022

publication date

1 August 1991

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1713814

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1713814%20AND%20SRC:MED&resulttype=core&format=json

retrieved

17 September 2019

full work available at URL

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1365-2249.1991.tb05726.x

1 reference

stated in

Crossref

DOI

10.1111/J.1365-2249.1991.TB05726.X

reference URL

https://api.crossref.org/works/10.1111/J.1365-2249.1991.TB05726.X

retrieved

6 November 2022

https://academic.oup.com/cei/article-pdf/85/2/317/42214363/j.1365-2249.1991.tb05726.x.pdf

file format

Portable Document Format

1 reference

stated in

Crossref

DOI

10.1111/J.1365-2249.1991.TB05726.X

reference URL

https://api.crossref.org/works/10.1111/J.1365-2249.1991.TB05726.X

retrieved

6 November 2022

published in

Clinical and Experimental Immunology

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1713814

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1713814%20AND%20SRC:MED&resulttype=core&format=json

retrieved

17 September 2019

volume

85

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1713814

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1713814%20AND%20SRC:MED&resulttype=core&format=json

retrieved

17 September 2019

issue

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1713814

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1713814%20AND%20SRC:MED&resulttype=core&format=json

retrieved

17 September 2019

page(s)

317-325

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1713814

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1713814%20AND%20SRC:MED&resulttype=core&format=json

retrieved

17 September 2019

cites work

Natural cell-mediated cytotoxicity in rats. II.In vivo augmentation of NK-cell activity

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/1713814

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identification of a cell-surface antigen selectively expressed on the natural killer cell

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/1713814

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Enhancement by interferon of the specific cytotoxicity of sensitized lymphocytes

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/1713814

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antigen(s)-specific tumour-infiltrating lymphocytes from tumour induced by human herpes virus-6 (HHV-6) DNA transfected NIH 3T3 transformants

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/1713814

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combination therapy with interleukin-2 and alpha-interferon for the treatment of patients with advanced cancer

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/1713814

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Induction of major histocompatibility class I antigens by interferons in undifferentiated F9 cells

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/1713814

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Murine lymphokine-activated killer (LAK) cells: phenotypic characterization of the precursor and effector cells

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/1713814

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Flow cytometric analysis reveals the presence of asialo GM1 on the surface membrane of alloimmune cytotoxic T lymphocytes

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/1713814

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Differential effects of recombinant interferons alpha, beta, and gamma on induction of human lymphokine (IL-2)-activated killer activity

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/1713814

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Eradication of mouse melanoma by combined treatment with recombinant human interleukin 2 and recombinant murine interferon-gamma

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/1713814

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interleukin-2 activated human killer lymphocytes: lack of involvement of interferon in the development of IL-2-activated killer lymphocytes

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/1713814

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vivo antitumor activity of multiple injections of recombinant interleukin 2, alone and in combination with three different types of recombinant interferon, on various syngeneic murine tumors

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/1713814

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interaction of recombinant interferons with recombinant interleukin-2: differential effects on natural killer cell activity and interleukin-2-activated killer cells

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/1713814

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hyporesponsiveness to augmentation of murine natural killer cell activity in different anatomical compartments by multiple injections of various immunomodulators including recombinant interferons and interleukin 2

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/1713814

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparative effects of various classes of mouse interferons on macrophage activation for tumor cell killing

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/1713814

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Induction of human lymphokine-activated killer cells by IFN-alpha and IFN-gamma.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/1713814

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Synergistic antitumor effects of combination immunotherapy with recombinant interleukin-2 and a recombinant hybrid alpha-interferon in the treatment of established murine hepatic metastases.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/1713814

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Synergistic antitumor effects of immunotherapy with recombinant interleukin-2 and recombinant tumor necrosis factor-alpha

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/1713814

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Establishment of monoclonal anti-Nk-1.1 antibody.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/1713814

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II trials of recombinant leukocyte A interferon in disseminated malignant melanoma: results in 96 patients.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/1713814

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibition of experimentally-induced murine metastases by recombinant alpha interferon: correlation between the modulatory effect of interferon treatment on natural killer cell activity and inhibition of metastases

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/1713814

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vivo anti-tumor activity of combinations of interferon alpha and interleukin-2 in a murine model. Correlation of efficacy with the induction of cytotoxic cells resembling natural killer cells

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/1713814

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/1713814

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interleukin 4 (B cell stimulatory factor 1) can mediate the induction of lymphokine-activated killer cell activity directed against fresh tumor cells

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/1713814

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recombinant interferon enhances monoclonal antibody-targeting of carcinoma lesions in vivo

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/1713814

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Direct antiproliferative effects of recombinant human interferon-alpha B/D hybrids on human tumor cell lines

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/1713814

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reactivity of anti-asialo GM1 serum with tumoricidal and non-tumoricidal mouse macrophages.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/1713814

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Systemic administration of recombinant interleukin 2 stimulates in vivo lymphoid cell proliferation in tissues

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/1713814

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Regression of established pulmonary metastases and subcutaneous tumor mediated by the systemic administration of high-dose recombinant interleukin 2.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/1713814

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vivo administration of interferon alpha and interleukin 2 induces proliferation of lymphoid cells in the organs of mice

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/1713814

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interactive effects of alpha-interferon A/D and interleukin 2 on murine lymphokine-activated killer activity: analysis at the effector and precursor level

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/1713814

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Augmentation of human natural cell-mediated cytotoxicity by recombinant human interleukin 2

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/1713814

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Partial reversion of the transformed phenotype of murine sarcoma virus-transformed cells in the presence of interferon: a possible mechanism for the anti-tumour effect of interferon.

series ordinal

20

2 references

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/1713814

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

stated in

Crossref

DOI

10.1111/J.1365-2249.1991.TB05726.X

reference URL

https://api.crossref.org/works/10.1111/J.1365-2249.1991.TB05726.X

retrieved

6 November 2022

Interleukin-2 augments natural killer cell activity

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/1713814

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/1713814

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antitumor effects of interferon in mice injected with interferon-sensitive and interferon-resistant Friend leukemia cells. I.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/1713814

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identification of ganglio-N-tetraosylceramide as a new cell surface marker for murine natural killer (NK) cells

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/1713814

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mechanism of the Antitumour Effect of Interferon in Mice

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/1713814

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long term culture of tumour-specific cytotoxic T cells

1 reference

stated in

COCI

retrieved

24 May 2022

reference URL

https://opencitations.net/index/coci/api/v1/citations/10.1038/268154A0

Quantification of natural cytotoxicity by human lymphocyte subpopulations isolated by density: Heterogeneity of the effector cells

series ordinal

2

1 reference

stated in

Crossref

DOI

10.1111/J.1365-2249.1991.TB05726.X

reference URL

https://api.crossref.org/works/10.1111/J.1365-2249.1991.TB05726.X

retrieved

6 November 2022

Synergism between alpha-interferon and interleukin-2-activated killer cells: in vitro studies

series ordinal

31

1 reference

stated in

Crossref

DOI

10.1111/J.1365-2249.1991.TB05726.X

reference URL

https://api.crossref.org/works/10.1111/J.1365-2249.1991.TB05726.X

retrieved

6 November 2022

Identifiers

DOI

10.1111/J.1365-2249.1991.TB05726.X

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1713814

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1713814%20AND%20SRC:MED&resulttype=core&format=json

retrieved

17 September 2019

PMC publication ID

1535732

1 reference

stated in

National Center for Biotechnology Information

PubMed publication ID

1713814

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1713814

retrieved

6 November 2022

PubMed publication ID

1713814

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1713814

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1713814%20AND%20SRC:MED&resulttype=core&format=json

retrieved

17 September 2019

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q67696139&oldid=1789209879"